HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Umezawa Selected Research

Methacholine Chloride (Methacholine)

8/2012Dehydroxymethylepoxyquinomicin (DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodelling in murine models of asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Umezawa Research Topics

Disease

7Neoplasms (Cancer)
11/2020 - 07/2005
2Inflammation (Inflammations)
08/2012 - 07/2011
2Necrosis
11/2011 - 01/2010
2Pancreatic Neoplasms (Pancreatic Cancer)
03/2010 - 10/2003
2Rheumatoid Arthritis
11/2006 - 08/2000
2Carcinoma (Carcinomatosis)
11/2006 - 01/2001
1Edema (Dropsy)
02/2017
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
02/2017
1Breast Neoplasms (Breast Cancer)
06/2013
1Glioblastoma (Glioblastoma Multiforme)
01/2013
1Ovarian Epithelial Carcinoma
09/2012
1Ascites
09/2012
1Prostatic Neoplasms (Prostate Cancer)
08/2012
1Asthma (Bronchial Asthma)
08/2012
1Respiratory Hypersensitivity
08/2012
1Airway Remodeling
08/2012
1Diabetes Mellitus
03/2010
1Tics (Tic)
01/2010
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2007
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2006
1Hepatocellular Carcinoma (Hepatoma)
11/2003
1Pulmonary Edema
03/2001
1Alzheimer Disease (Alzheimer's Disease)
11/2000
1Neuroblastoma
11/2000
1Dementia (Dementias)
11/2000
1Albuminuria
06/2000
1Experimental Arthritis
05/2000
1T-Cell Leukemia (Leukemia, T Cell)
05/2000
1Adenocarcinoma
01/2000

Drug/Important Bio-Agent (IBA)

5NF-kappa B (NF-kB)IBA
08/2012 - 05/2000
4dehydroxymethylepoxyquinomicinIBA
01/2013 - 07/2005
3conophyllineIBA
03/2010 - 10/2003
2Transcription Factors (Transcription Factor)IBA
08/2012 - 07/2011
2AlkaloidsIBA
03/2010 - 11/2003
2Transforming Growth Factor beta (TGF-beta)IBA
01/2010 - 11/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2000 - 05/2000
1ThrombomodulinIBA
02/2017
1ChemokinesIBA
06/2013
1Temozolomide (Temodar)FDA LinkGeneric
01/2013
1Phosphotransferases (Kinase)IBA
09/2012
1Interleukin-6 (Interleukin 6)IBA
09/2012
1LigandsIBA
09/2012
1tyrosine receptor (receptor, tyrosine)IBA
09/2012
1ErbB Receptors (EGF Receptor)IBA
09/2012
1Plasminogen Activator Inhibitor 1IBA
09/2012
1CytokinesIBA
08/2012
1Methacholine Chloride (Methacholine)FDA Link
08/2012
1LipopolysaccharidesIBA
11/2011
1Antineoplastic Agents (Antineoplastics)IBA
07/2011
1Blood Glucose (Blood Sugar)IBA
03/2010
1Streptozocin (Streptozotocin)FDA Link
03/2010
1Pork Regular Insulin (Velosulin)FDA Link
03/2010
1Biomarkers (Surrogate Marker)IBA
01/2010
1InterferonsIBA
01/2010
1Monoclonal AntibodiesIBA
09/2007
1Rituximab (Mabthera)FDA Link
09/2007
1Small Interfering RNA (siRNA)IBA
09/2007
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
09/2007
1CollagenIBA
11/2006
1fludarabineIBA
05/2006
1Insulin (Novolin)FDA Link
10/2003
11-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)IBA
01/2001
1ApolipoproteinsIBA
11/2000
1Apolipoprotein E4IBA
11/2000
1GTP Phosphohydrolases (GTPases)IBA
11/2000
1Apolipoprotein E3IBA
11/2000
1Therapeutic UsesIBA
08/2000
1pimagedine (aminoguanidine)IBA
06/2000
1CreatinineIBA
06/2000
1chloptosinIBA
01/2000

Therapy/Procedure

2Radiotherapy
11/2020 - 08/2012
2Therapeutics
01/2013 - 03/2010
2Drug Therapy (Chemotherapy)
09/2007 - 05/2006
1Hematopoietic Stem Cell Transplantation
02/2017
1General Anesthesia
03/2001